Head-to-Head Comparison: The SURPASS-2 Trial In the SURPASS-2 trial , Tirzepatide and Semaglutide were directly compared in individuals with type 2 diabetes: Patients on 15 mg of Tirzepatide lost an average of 11.2 kg (~24.7 lbs)
B12 interaction with metformin: Many semaglutide users also take metformin for type 2 diabetes management
Being able to return to previously limited activities often matters more than achieving a completely pain-free state
10.1053/j.gastro.2004.03.013 Gastroenterology 32 Cohen KadoshK.BassoM.KnytlP.JohnstoneN.LauJ
Systemic diseases, including endocrine disorders, can impair liver function, leading to hepatic inflammation, enzyme abnormalities, and various structural changes such as steatosis, hypoxic injury, or calcification
This simple swap often eliminates pizza-related discomfort and allows patients to eat their preferred foods without nausea